Janus Henderson Group
ELGX

Janus Henderson Group’s Endologix Inc ELGX Stock Holding History

Janus Henderson Group’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,283
Closed -$24K – 1462
2018
Q3 		$24K Buy
1,283
+254
+25% +$9.06K ﹤0.01% 1442
2018
Q2 		$58K Buy
+1,029
New +$52.2K ﹤0.01% 1385

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Janus Henderson Group's ELGX Position: Q4 2018 in Review

Janus Henderson Group sold out of Endologix Inc (ELGX) in Q4 2018, closing a stake of 1,283 shares — an estimated $24K sold.

Janus Henderson Group first reported a position in ELGX in Q2 2018 and held it in 2 quarters. The position peaked at $58K in Q2 2018. 99 funds tracked by Wall St. Rank hold ELGX as of Q4 2018.

  • Janus Henderson Group reported no remaining Endologix Inc position as of Q4 2018 after selling out during the quarter.
  • Janus Henderson Group sold 1,283 Endologix Inc shares in Q4 2018, an estimated $24K.
  • Janus Henderson Group first reported a position in Endologix Inc in Q2 2018 and held it in 2 quarters.
  • Janus Henderson Group's Endologix Inc position peaked at $58K in Q2 2018.
  • 99 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2018.

Based on Janus Henderson Group's 13F filing for Q4 2018, filed 6 Feb 2019.